BALTIMORE, MD – The International Vaccine Access Center (IVAC) at the Johns Hopkins Bloomberg School of Public Health (JHSPH) announced today recipients of the 2012 Small Grants for World Pneumonia Day Advocacy Program. The Small Grants Program supports events and activities that promote pneumonia prevention and control in countries where childhood pneumonia has the greatest impact.
In this, the 4th year of the small grants program, 12 grants have been awarded thus far and additional grants may be announced later in the year. Congratulations to the following Recipient Organizations:
Pneumonia is the world's leading killer of children under five, claiming nearly 1.3 million children under five years of age in 2011, over 90% of whom are in developing countries. Over the last decade, global health leaders have worked to turn the tide on pneumonia by promoting access to interventions that protect against, prevent, and treat the disease for the children who need them most. In this spirit, a diverse group of advocacy, academic, and service organizations formed the Global Coalition Against Child Pneumonia in 2009. The Coalition recognizes a World Pneumonia Day each year to raise awareness of the disease and advocate for funding and implementation of proven interventions.
Commemorated annually on November 12th, World Pneumonia Day has earned the attention of public health leaders, medical professionals, journalists, policy-makers and community advocates as a day to raise awareness and create action to combat this "forgotten killer."
The Small Grants Program is made possible through support from members of the Global Coalition against Child Pneumonia including IVAC, the GAVI Alliance and the Global Alliance for Clean Cookstoves.
Visit www.worldpneumoniaday.org for more information about the 2012 Small Grants for Advocacy Program and World Pneumonia Day.
The Global Coalition Against Child Pneumonia was established in 2009 to raise awareness about the toll of pneumonia, the world's leading killer of children. Comprised of over 140 nongovernmental organizations, academic institutions, government agencies, and foundations, the Coalition provides leadership for World Pneumonia Day, advocating for global action to protect against, effectively treat and help prevent this deadly disease.
The International Vaccine Access Center (IVAC) has as its mission to accelerate global access to life-saving vaccines through development and implementation of evidence-based policies. Drawing upon expertise and faculty from the Johns Hopkins Bloomberg School of Public Health, IVAC works to strengthen the evidence base for vaccine introduction including undertaking targeted, policy-focused research in areas such as disease burden, cost-effectiveness, vaccine policy, demand forecasting and disease epidemiology. For more information, please visit www.jhsph.edu/ivac.
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.